Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: Infant Malaria Vaccine Schedule Optimization [Phase 2]

View source ↗

Summary

PATH is conducting a Phase 2 study to optimize the vaccination schedule for an infant malaria vaccine, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Malaria vaccine (unspecified)

Snippet

Sponsor: PATH | Conditions: Malaria Vaccines | Phase 2 | Status: RECRUITING